接骨木莓 Elderberry × 流感

結論:證據分歧

The evidence for elderberry as a flu treatment is small, old, conflicted, and inconsistent.

C 🟠 C 薄弱證據 證據分歧 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示

The evidence for elderberry as a flu treatment is small, old, conflicted, and inconsistent. The positive flagship results (Zakay-Rones 2004 RCT, n=60; 2019 meta-analysis, n=180) rest on tiny, single-site, decades-old trials using the manufacturer-linked Sambucol product with poorly disclosed funding. The most recent and most rigorous RCT (Macknin 2020, n=87) found NO meaningful benefit and a possible negative post-hoc signal, and the 2021 NIH-funded systematic review rated overall certainty as low-to-very-low (GRADE). Examine itself grades this condition only C (1 study, n=87). A modest signal exists but is contradicted by the strongest data, so the totality supports a C — evidence exists but is small, inconsistent, and uncertain, and is best characterized as disputed rather than established.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.40
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
75%
證據方向大致一致
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.22
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.403
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review
PMID: 33827515 2021 系統性回顧
結論:Five RCTs screened from 1187 records. Elderberry may reduce the duration of influenza but the evidence is uncertain (low to very low GRADE certainty). Compared with oseltamivir, an elderberry-containing product may be associated with a lower risk of influenza complications and adverse events. No studies linked elderberry to clinical inflammatory outcomes; three ex vivo cytokine studies found no evidence that elderberry overstimulates the immune system, so the theoretical cytokine-storm concern was not borne out.
政府資助 效應量:Not pooled; estimates characterized as very uncertain
前往 PubMed
Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
PMID: 30670267 2019 統合分析 n = 180
結論:Pooled analysis of RCTs (180 participants) reported that elderberry supplementation substantially reduced upper respiratory symptom duration, with a large mean effect size (~1.717). Authors framed elderberry as a potentially safer alternative for routine cold and flu. The small pooled sample and reliance on the older Sambucol trials limit generalizability.
🟠 品質有限 效應量:Large (Hedges g approx 1.7)
前往 PubMed
Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial
PMID: 32929634 2020 隨機對照試驗 n = 87
結論:No meaningful benefit. Time to symptom improvement was 4.9 days (placebo) vs 5.3 days (elderberry), p=0.57; complete resolution 8.7 vs 8.6 days, p=0.87. Post hoc analysis suggested outcomes with elderberry taken alone (without oseltamivir) were about 2 days worse than placebo alone. This is the most recent and most rigorous trial and contradicts the earlier positive studies.
效應量:Negligible / non-significant; possible negative signal in post hoc subgroup
前往 PubMed
Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections
PMID: 15080016 2004 隨機對照試驗 n = 60
結論:Patients receiving elderberry extract experienced symptom relief on average about 4 days earlier than the placebo group, with significantly reduced rescue medication use. This is the flagship Zakay-Rones trial; small sample, single site, and the elderberry product (Sambucol) is industry-linked. Authors stated findings require confirmation in a larger trial.
🟠 品質有限 效應量:Symptom relief ~4 days earlier (no CI reported)
前往 PubMed

L4a US FDA
謹慎
ELDER FLOWERS, EXTRACT (SAMBUCUS CANADENSIS L. OR SAMBUCUS NIGRA L.) — 21 CFR 182.20 — FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT 來源↗
L4b EU EFSA
中性
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
接骨木莓(Sambucus nigra)果實得供食品使用;惟接骨木之葉、莖、樹皮、未成熟果實及種子含氰苷成分,不得供食品使用。 來源↗
L4e WHO
未表態
Although no controlled clinical data are available, the descriptions in pharmacopoeias and traditional systems of medicine justify the use of Flos Sambuci as a diaphoretic for treatment of fever and chills, and as an expectorant for treatment of mild inflammation of the upper respiratory tract; also for symptomatic treatment of the common cold. 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
反對
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
反對

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

PTT/Dcard/Mobile01 幾乎無針對「接骨木莓 for 流感」的真實鄉民討論串;搜尋結果幾乎全是業配比較文與品牌部落格(樂活選物、健康醫學院、Hello醫師、蘇摸摸、悠活原力等)借「PTT/Dcard 推薦」之名行帶貨之實,缺乏可信的在地實測經驗。業配污染極高。

💬社群實感

無共識(無真實社群討論,搜尋僅見業配比較文,非鄉民實測)

破解迷思 社群最常見的 2 個誤解
事實業配文常宣稱「縮短病程約3-4天」直接套用在台灣讀者,但此數據來自小型海外試驗,非台灣社群實測共識
事實比較文以「PTT/Dcard 熱門推薦」為標題吸引點擊,實際 PTT/Dcard 並無對應討論串,屬行銷話術
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • Sambucol 善倍康
  • 大研生醫 冒易舒接骨木莓粉包
  • WEDAR 接骨木莓+C
  • 悠活原力
  • 你滋美得

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

Sambucol 接骨木軟糖,30 粒裝

代表來源 ↗
L10b · TFDA 法定身份 官方認定
🍽️一般食品

食品之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形。食品不得為醫療效能之標示、宣傳或廣告。

來源 ↗

  • 流感疫苗接種
  • 抗病毒藥物(如 oseltamivir、baloxavir)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-influenza-INT-elderberry-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-influenza-INT-elderberry-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "接骨木莓能改善流感",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}